COM:ALXONCOLOGY
ALX Oncology Holdings Inc.
- Stock
Last Close
1.29
22/11 21:00
Market Cap
352.20M
Beta: -
Volume Today
966.09K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -8.85M - | ||||||
average payables | 2.22M - | 1.88M 15.59% | 1.88M 0.43% | 5.92M 214.15% | 8.33M 40.78% | ||
average receivables | 734K - | 268K 63.49% | 500K - | ||||
book value per share | 0.42 - | -0.01 103.01% | -6.41 50,894.56% | -5.01 21.85% | -8.00 59.58% | 0.00 100.06% | |
capex per share | -0.03 - | -0.02 45.94% | -0.00 89.57% | -0.12 7,182.89% | -0.04 71.29% | -0.00 99.92% | |
capex to depreciation | -1.52 - | -0.82 45.69% | -0.15 81.35% | -96.53 62,799.81% | -4.17 95.68% | 0.23 105.40% | |
capex to operating cash flow | 0.05 - | 0.02 49.96% | 0.00 96.73% | 0.07 8,828.71% | 0.02 77.88% | 0.01 38.90% | |
capex to revenue | -0.32 - | -0.07 76.70% | -0.03 64.37% | ||||
cash per share | 0.38 - | 0.41 9.14% | 23.49 5,618.48% | 9.02 61.59% | 12.29 36.24% | 0.00 99.97% | |
days of inventory on hand | |||||||
days payables outstanding | 135.32 - | 313.77 131.87% | 1.36 99.57% | ||||
days sales outstanding | 164.58 - | 40.79 75.21% | |||||
debt to assets | 0.51 - | 0.00 - | 0.03 1,643.65% | ||||
debt to equity | -19.64 - | -0.00 - | -0.03 772.35% | ||||
dividend yield | 0.00 - | ||||||
earnings yield | -0.02 - | -0.03 40.14% | -0.03 1.76% | -0.10 235.66% | -0.27 179.40% | -0.00 99.91% | |
enterprise value | 650.28M - | 654.94M 0.72% | 1.16B 76.99% | 503.29M 56.58% | 186.21M 63.00% | 640.07B 343,635.66% | |
enterprise value over ebitda | -49.06 - | -34.91 28.83% | -26.31 24.65% | -6.03 77.08% | -1.46 75.77% | -3.76K 257,151.65% | |
ev to operating cash flow | -49.30 - | -45.96 6.77% | -30.28 34.13% | -7.39 75.59% | -2.09 71.76% | -4.91K 235,157.64% | |
ev to sales | 314.60 - | 136.56 56.59% | 980.73 618.16% | ||||
free cash flow per share | -0.63 - | -0.67 5.48% | -2.07 211.64% | -1.81 12.61% | -2.23 22.94% | -0.00 99.86% | |
free cash flow yield | -0.02 - | -0.02 5.48% | -0.02 8.46% | -0.08 250.55% | -0.20 134.43% | -0.00 99.90% | |
graham net net | 0.32 - | -0.07 122.05% | -0.10 42.14% | 8.60 8,760.53% | 11.24 30.69% | 0.00 99.97% | |
graham number | 2.42 - | 0.50 79.45% | 18.89 3,693.94% | 15.28 19.13% | 23.36 52.92% | 0.02 99.92% | |
income quality | 0.96 - | 0.74 22.92% | 0.84 13.05% | 0.82 2.53% | 0.72 11.44% | 0.81 12.20% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -913.48 - | -53.84 94.11% | -6.43K 11,838.13% | 29.23 100.45% | 108.80 272.25% | ||
interest debt per share | 0.25 - | 0.04 82.30% | 0.02 57.31% | 0.15 696.24% | -0.00 100.02% | ||
inventory turnover | |||||||
invested capital | -19.64 - | -0.00 - | -0.03 772.35% | ||||
market cap | 658.54M - | 658.54M 0% | 1.59B 141.96% | 866.22M 45.64% | 458.68M 47.05% | 640.09B 139,448.57% | |
net current asset value | 8.20M - | -1.14M 113.94% | -1.83M 60.54% | 349.88M 19,167.30% | 227.94M 34.85% | 135.82M 40.42% | |
net debt to ebitda | 0.62 - | 0.19 69.25% | 9.85 5,040.26% | 4.35 55.87% | 2.14 50.82% | 0.13 93.85% | |
net income per share | -0.63 - | -0.88 40.14% | -2.47 182.27% | -2.07 16.32% | -3.03 46.52% | -0.00 99.88% | |
operating cash flow per share | -0.60 - | -0.65 8.03% | -2.07 219.10% | -1.69 18.43% | -2.19 29.76% | -0.00 99.86% | |
payables turnover | 2.70 - | 1.16 56.87% | 268.75 23,002.64% | ||||
receivables turnover | 2.22 - | 8.95 303.45% | |||||
research and ddevelopement to revenue | 5.45 - | 3.40 37.64% | 24.50 620.66% | ||||
return on tangible assets | -1.23 - | -1.80 46.55% | -0.10 94.18% | -0.22 109.29% | -0.40 83.52% | -0.66 64.55% | |
revenue per share | 0.09 - | 0.22 132.03% | 0.06 70.73% | ||||
roe | -1.50 - | 69.72 4,748.58% | 0.39 99.45% | 0.41 7.07% | 0.38 8.18% | -0.85 323.41% | |
roic | -1.50 - | -3.74 149.07% | 0.37 109.92% | 0.42 12.50% | 0.41 2.54% | -0.90 321.04% | |
sales general and administrative to revenue | 1.26 - | 0.69 45.10% | 12.53 1,713.70% | ||||
shareholders equity per share | 0.42 - | -0.01 103.01% | -6.41 50,894.56% | -5.01 21.85% | -8.00 59.58% | 0.00 100.06% | |
stock based compensation to revenue | 0.13 - | 0.06 52.42% | 4.60 7,326.51% | ||||
tangible asset value | 9.15M - | -276K 103.01% | 363.05M - | 263.46M 27.43% | 189.71M 27.99% | ||
tangible book value per share | 0.42 - | -0.01 103.01% | 9.01 - | 6.47 28.13% | 0.00 99.93% | ||
working capital | 8.34M - | 4.83M 42.11% | 428.01M 8,770.78% | 351.72M 17.82% | 242.64M 31.01% | 152.66M 37.09% |
All numbers in USD (except ratios and percentages)